dextroamphetamine has been researched along with Precancerous Conditions in 1 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Precancerous Conditions: Pathological conditions that tend eventually to become malignant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Miglio, MR | 1 |
| Muroni, MR | 1 |
| Simile, MM | 1 |
| Calvisi, DF | 1 |
| Tolu, P | 1 |
| Deiana, L | 1 |
| Carru, A | 1 |
| Bonelli, G | 1 |
| Feo, F | 1 |
| Pascale, RM | 1 |
1 other study available for dextroamphetamine and Precancerous Conditions
| Article | Year |
|---|---|
Implication of Bcl-2 family genes in basal and D-amphetamine-induced apoptosis in preneoplastic and neoplastic rat liver lesions.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Coloring Agents; Dextroamphetamine; Diethylnitrosami | 2000 |